Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Bergum, PW; Cruikshank, A; Maki, SL; Kelly, CR; Ruf, W; Vlasuk, GP
   Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2
   JOURNAL OF BIOLOGICAL CHEMISTRY
   
   P.W. Bergum et al., "Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2", J BIOL CHEM, 276(13), 2001, pp. 10063-10071
2. Friederich, PW; Levi, M; Bauer, KA; Vlasuk, GP; Rote, WE; Breederveld, D; Keller, T; Spataro, M; Barzegar, S; Buller, HR
   Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects
   CIRCULATION
   
   P.W. Friederich et al., "Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects", CIRCULATION, 103(21), 2001, pp. 2555-2559
3. Inan, M; Chiruvolu, V; Eskridge, KM; Vlasuk, GP; Dickerson, K; Brown, S; Meagher, MM
   Optimization of temperature-glycerol-pH conditions for a fed-batch fermentation process for recombinant hookworm (Ancylostoma caninum) anticoagulant peptide (AcAP-5) production by Pichia pastoris
   ENZYME AND MICROBIAL TECHNOLOGY
   
   M. Inan et al., "Optimization of temperature-glycerol-pH conditions for a fed-batch fermentation process for recombinant hookworm (Ancylostoma caninum) anticoagulant peptide (AcAP-5) production by Pichia pastoris", ENZYME MICR, 24(7), 1999, pp. 438-445
4. VLASUK GP
   NOVEL ANTICOAGULANTS - OVERVIEW
   Coronary artery disease
   
   G.P. Vlasuk, "NOVEL ANTICOAGULANTS - OVERVIEW", Coronary artery disease, 9(2-3), 1998, pp. 61-64
5. VLASUK GP
   THE NEW ANTICOAGULANTS - NEW OPPORTUNITIES, NEW ISSUES
   Archives of pathology and laboratory medicine
   
   G.P. Vlasuk, "THE NEW ANTICOAGULANTS - NEW OPPORTUNITIES, NEW ISSUES", Archives of pathology and laboratory medicine, 122(9), 1998, pp. 812-814
6. VLASUK GP; BERGUM PW; ROTE WE; RUF W
   MECHANISTIC AND PHARMACOLOGICAL EVALUATION OF NAPC2, A NOVEL SMALL PROTEIN INHIBITOR OF THE FACTOR VIIA TISSUE FACTOR COMPLEX
   Thrombosis and haemostasis
   
   G.P. Vlasuk et al., "MECHANISTIC AND PHARMACOLOGICAL EVALUATION OF NAPC2, A NOVEL SMALL PROTEIN INHIBITOR OF THE FACTOR VIIA TISSUE FACTOR COMPLEX", Thrombosis and haemostasis, 1997, pp. 2807-2807
7. REBELLO SS; BLANK HS; ROTE WE; VLASUK GP; LUCCHESI BR
   ANTITHROMBOTIC EFFICACY OF A RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5) IN CANINE MODELS OF THROMBOSIS AFTER SINGLE SUBCUTANEOUS ADMINISTRATION
   The Journal of pharmacology and experimental therapeutics
   
   S.S. Rebello et al., "ANTITHROMBOTIC EFFICACY OF A RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5) IN CANINE MODELS OF THROMBOSIS AFTER SINGLE SUBCUTANEOUS ADMINISTRATION", The Journal of pharmacology and experimental therapeutics, 283(1), 1997, pp. 91-99
8. BETZ A; VLASUK GP; BERGUM PW; KRISHNASWAMY S
   SELECTIVE-INHIBITION OF THE PROTHROMBINASE COMPLEX - FACTOR VA ALTERSMACROMOLECULAR RECOGNITION OF A TICK ANTICOAGULANT PEPTIDE MUTANT BY FACTOR XA
   Biochemistry
   
   A. Betz et al., "SELECTIVE-INHIBITION OF THE PROTHROMBINASE COMPLEX - FACTOR VA ALTERSMACROMOLECULAR RECOGNITION OF A TICK ANTICOAGULANT PEPTIDE MUTANT BY FACTOR XA", Biochemistry, 36(1), 1997, pp. 181-191
9. VLASUK GP; BERGUM PW; BRADBURY AE; LOYNDS P; MANT TGK; ROTE WE
   CLINICAL-EVALUATION OF RNAPC2, AN INHIBITOR OF THE FVIIA TISSUE FACTOR COAGULATION COMPLEX/
   The American journal of cardiology
   
   G.P. Vlasuk et al., "CLINICAL-EVALUATION OF RNAPC2, AN INHIBITOR OF THE FVIIA TISSUE FACTOR COAGULATION COMPLEX/", The American journal of cardiology, 80, 1997, pp. 239-239
10. KRISHNAN R; TULINSKY A; VLASUK GP; PEARSON D; VALLAR P; BERGUM P; BRUNCK TK; RIPKA WC
    SYNTHESIS, STRUCTURE, AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF DIVALENT THROMBIN INHIBITORS CONTA AN ALPHA-KETO-AMIDE TRANSITION-STATE MIMETIC
    Protein science
    
    R. Krishnan et al., "SYNTHESIS, STRUCTURE, AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF DIVALENT THROMBIN INHIBITORS CONTA AN ALPHA-KETO-AMIDE TRANSITION-STATE MIMETIC", Protein science, 5(3), 1996, pp. 422-433
11. ROTE WE; DEMPSEY E; MAKI S; VLASUK GP; MOYLE M
    THE ROLE OF CD11 CD18 INTEGRINS IN THE REVERSE PASSIVE ARTHUS REACTION IN RAT DERMAL TISSUE/
    Journal of leukocyte biology
    
    W.E. Rote et al., "THE ROLE OF CD11 CD18 INTEGRINS IN THE REVERSE PASSIVE ARTHUS REACTION IN RAT DERMAL TISSUE/", Journal of leukocyte biology, 59(2), 1996, pp. 254-261
12. STANSSENS P; BERGUM PW; GANSEMANS Y; JESPERS L; LAROCHE Y; HUANG S; MAKI S; MESSENS J; LAUWEREYS M; CAPPELLO M; HOTEZ PJ; LASTERS I; VLASUK GP
    ANTICOAGULANT REPERTOIRE OF THE HOOKWORM ANCYLOSTOMA-CANINUM
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    P. Stanssens et al., "ANTICOAGULANT REPERTOIRE OF THE HOOKWORM ANCYLOSTOMA-CANINUM", Proceedings of the National Academy of Sciences of the United Statesof America, 93(5), 1996, pp. 2149-2154
13. MAKI SL; RUF W; HUANG S; KELLY C; VLASUK GP
    NEMATODE ANTICOAGULANT PROTEIN C2 (C2) - A POTENT INHIBITOR OF FACTORVIIA TISSUE FACTOR COMPLEX (FVIIA/TF) REQUIRES AN EXOSITE ON FACTOR XA (FXA) THAT OVERLAPS A FACTOR VA (FVA) BINDING-SITE/
    Circulation
    
    S.L. Maki et al., "NEMATODE ANTICOAGULANT PROTEIN C2 (C2) - A POTENT INHIBITOR OF FACTORVIIA TISSUE FACTOR COMPLEX (FVIIA/TF) REQUIRES AN EXOSITE ON FACTOR XA (FXA) THAT OVERLAPS A FACTOR VA (FVA) BINDING-SITE/", Circulation, 94(8), 1996, pp. 4057-4057
14. ROTE WE; OLDESCHULLE GL; DEMPSEY EM; VLASUK GP
    EVALUATION OF A NOVEL SMALL PROTEIN INHIBITOR OF THE BLOOD-COAGULATION FACTOR VIIA TISSUE FACTOR COMPLEX IN ANIMAL-MODELS OF ARTERIAL AND VENOUS THROMBOSIS/
    Circulation
    
    W.E. Rote et al., "EVALUATION OF A NOVEL SMALL PROTEIN INHIBITOR OF THE BLOOD-COAGULATION FACTOR VIIA TISSUE FACTOR COMPLEX IN ANIMAL-MODELS OF ARTERIAL AND VENOUS THROMBOSIS/", Circulation, 94(8), 1996, pp. 4064-4064
15. BERKELEY CJ; VLASUK GP; ROTE WE
    COMPARISON OF NEMATODE ANTICOAGULANT PROTEINS (NAPS) WITH LOW-MOLECULAR-WEIGHT HEPARIN IN A MODEL OF DISSEMINATED INTRAVASCULAR COAGULATION(DIC)
    Circulation
    
    C.J. Berkeley et al., "COMPARISON OF NEMATODE ANTICOAGULANT PROTEINS (NAPS) WITH LOW-MOLECULAR-WEIGHT HEPARIN IN A MODEL OF DISSEMINATED INTRAVASCULAR COAGULATION(DIC)", Circulation, 94(8), 1996, pp. 4071-4071
16. COUSINS GR; FRIEDRICHS GS; SUDO Y; REBELLO SS; ROTE WE; VLASUK GP; NOLAN TG; MENDOZA C; LUCCHESI BR
    ORALLY EFFECTIVE CVS-1123 PREVENTS CORONARY-ARTERY THROMBOSIS IN THE CONSCIOUS DOG
    Circulation
    
    G.R. Cousins et al., "ORALLY EFFECTIVE CVS-1123 PREVENTS CORONARY-ARTERY THROMBOSIS IN THE CONSCIOUS DOG", Circulation, 94(7), 1996, pp. 1705-1712
17. BIEMOND BJ; FRIEDERICH PW; LEVI M; VLASUK GP; BULLER HR; TENCATE JW
    COMPARISON OF SUSTAINED ANTITHROMBOTIC EFFECTS OF INHIBITORS OF THROMBIN AND FACTOR XA IN EXPERIMENTAL THROMBOSIS
    Circulation
    
    B.J. Biemond et al., "COMPARISON OF SUSTAINED ANTITHROMBOTIC EFFECTS OF INHIBITORS OF THROMBIN AND FACTOR XA IN EXPERIMENTAL THROMBOSIS", Circulation, 93(1), 1996, pp. 153-160
18. ORVIM U; BARSTAD RM; VLASUK GP; SAKARIASSEN KS
    EFFECT OF SELECTIVE FACTOR XA INHIBITION ON ARTERIAL THROMBUS FORMATION TRIGGERED BY TISSUE FACTOR FACTOR VIIA OR COLLAGEN IN AN EX-VIVO MODEL OF SHEAR-DEPENDENT HUMAN THROMBOGENESIS/
    Arteriosclerosis, thrombosis, and vascular biology
    
    U. Orvim et al., "EFFECT OF SELECTIVE FACTOR XA INHIBITION ON ARTERIAL THROMBUS FORMATION TRIGGERED BY TISSUE FACTOR FACTOR VIIA OR COLLAGEN IN AN EX-VIVO MODEL OF SHEAR-DEPENDENT HUMAN THROMBOGENESIS/", Arteriosclerosis, thrombosis, and vascular biology, 15(12), 1995, pp. 2188-2194
19. LYLE EM; FUJITA T; CONNER MW; CONNOLLY TM; VLASUK GP; LYNCH JL
    EFFECT OF INHIBITORS OF FACTOR X(A) OR PLATELET-ADHESION, HEPARIN, AND ASPIRIN ON PLATELET DEPOSITION IN AN ATHEROSCLEROTIC RABBIT MODEL OFANGIOPLASTY INJURY
    Journal of pharmacological and toxicological methods
    
    E.M. Lyle et al., "EFFECT OF INHIBITORS OF FACTOR X(A) OR PLATELET-ADHESION, HEPARIN, AND ASPIRIN ON PLATELET DEPOSITION IN AN ATHEROSCLEROTIC RABBIT MODEL OFANGIOPLASTY INJURY", Journal of pharmacological and toxicological methods, 33(1), 1995, pp. 53-61
20. LIMWILBY MSL; HALLENGA K; DEMAEYER M; LASTERS I; VLASUK GP; BRUNCK TK
    NMR STRUCTURE DETERMINATION OF TICK ANTICOAGULANT PEPTIDE (TAP)
    Protein science
    
    M.S.L. Limwilby et al., "NMR STRUCTURE DETERMINATION OF TICK ANTICOAGULANT PEPTIDE (TAP)", Protein science, 4(2), 1995, pp. 178-186
21. JESPERS LS; MESSENS JH; DEKEYSER A; EECKHOUT D; VANDENBRANDE I; GANSEMANS YG; LAUWEREYS MJ; VLASUK GP; STANSSENS PE
    SURFACE EXPRESSION AND LIGAND-BASED SELECTION OF CDNAS FUSED TO FILAMENTOUS PHAGE GENE VI
    Bio/technology
    
    L.S. Jespers et al., "SURFACE EXPRESSION AND LIGAND-BASED SELECTION OF CDNAS FUSED TO FILAMENTOUS PHAGE GENE VI", Bio/technology, 13(4), 1995, pp. 378-382
22. LYNCH JJ; SITKO GR; LEHMAN ED; VLASUK GP
    PRIMARY PREVENTION OF CORONARY ARTERIAL THROMBOSIS WITH THE FACTOR XAINHIBITOR RTAP IN A CANINE ELECTROLYTIC INJURY MODEL
    Thrombosis and haemostasis
    
    J.J. Lynch et al., "PRIMARY PREVENTION OF CORONARY ARTERIAL THROMBOSIS WITH THE FACTOR XAINHIBITOR RTAP IN A CANINE ELECTROLYTIC INJURY MODEL", Thrombosis and haemostasis, 74(2), 1995, pp. 640-645
23. ORVIM U; BARSTAD RM; VLASUK GP; SAKARIASSEN KS
    EFFECT OF SELECTIVE FACTOR-XA INHIBITION ON ARTERIAL THROMBUS FORMATION TRIGGERED BY TISSUE FACTOR FACTOR-VIIA AND COLLAGEN IN AN EX-VIVO MODEL OF HUMAN SHEAR-DEPENDENT THROMBOGENESIS
    Thrombosis and haemostasis
    
    U. Orvim et al., "EFFECT OF SELECTIVE FACTOR-XA INHIBITION ON ARTERIAL THROMBUS FORMATION TRIGGERED BY TISSUE FACTOR FACTOR-VIIA AND COLLAGEN IN AN EX-VIVO MODEL OF HUMAN SHEAR-DEPENDENT THROMBOGENESIS", Thrombosis and haemostasis, 73(6), 1995, pp. 1186-1186
24. VLASUK GP; BERGUM PW; BRUNCK TK; CAPPELLO M; DEMPSEY EM; GANSEMANS Y; HERMAN S; HOTEZ PJ; HUANG S; LAROCHE Y; LASTERS I; LAUWEREYS M; MAKI S; MESSENS J; PERSIAU G; ROTE WE; STANSSENS P; VANHOUTVEN A
    ANTICOAGULANT REPERTOIRE OF HEMATOPHAGOUS NEMATODES
    Thrombosis and haemostasis
    
    G.P. Vlasuk et al., "ANTICOAGULANT REPERTOIRE OF HEMATOPHAGOUS NEMATODES", Thrombosis and haemostasis, 73(6), 1995, pp. 1305-1305
25. CAPPELLO M; VLASUK GP; BERGUM PW; HUANG S; HOTEZ PJ
    ANCYLOSTOMA-CANINUM ANTICOAGULANT PEPTIDE - A HOOKWORM-DERIVED INHIBITOR OF HUMAN COAGULATION-FACTOR XA
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    M. Cappello et al., "ANCYLOSTOMA-CANINUM ANTICOAGULANT PEPTIDE - A HOOKWORM-DERIVED INHIBITOR OF HUMAN COAGULATION-FACTOR XA", Proceedings of the National Academy of Sciences of the United Statesof America, 92(13), 1995, pp. 6152-6156
26. COUSINS GR; FRIEDRICHS GS; SUDO YJ; ROTE WE; VLASUK GP; NOLAN T; MENDOZA C; LUCCHESI BR
    ORALLY EFFECTIVE CVS-1123 PREVENTS CORONARY-ARTERY THROMBOSIS IN THE CONSCIOUS CANINE
    Circulation
    
    G.R. Cousins et al., "ORALLY EFFECTIVE CVS-1123 PREVENTS CORONARY-ARTERY THROMBOSIS IN THE CONSCIOUS CANINE", Circulation, 92(8), 1995, pp. 1442-1442
27. ROTE WE; VLASUK GP
    EVALUATION OF A NOVEL SMALL PROTEIN INHIBITOR OF BLOOD-COAGULATION FACTOR XA (RNAP-5) IN A PORCINE MODEL OF ACUTE CORONARY-ARTERY THROMBOSIS
    Circulation
    
    W.E. Rote e G.P. Vlasuk, "EVALUATION OF A NOVEL SMALL PROTEIN INHIBITOR OF BLOOD-COAGULATION FACTOR XA (RNAP-5) IN A PORCINE MODEL OF ACUTE CORONARY-ARTERY THROMBOSIS", Circulation, 92(8), 1995, pp. 2322-2322
28. VLASUK GP; DEMPSEY EM; OLDESCHULTE GL; BERNARDINO VT; RICHARD BM; ROTE WE
    EVALUATION OF A NOVEL SMALL PROTEIN INHIBITOR OF BLOOD-COAGULATION FACTOR XA (RNAP-5) IN ANIMAL-MODELS OF THROMBOSIS
    Circulation
    
    G.P. Vlasuk et al., "EVALUATION OF A NOVEL SMALL PROTEIN INHIBITOR OF BLOOD-COAGULATION FACTOR XA (RNAP-5) IN ANIMAL-MODELS OF THROMBOSIS", Circulation, 92(8), 1995, pp. 3287-3287
29. BERGUM PW; MAKI SL; HUANG S; BENHAM PP; VLASUK GP
    THE ANTICOAGULANT STRATEGY OF THE HOOKWORM A-CANINUM - POTENT INHIBITION OF HUMAN-FACTORS XA (FXA) AND VIIA TF BY A UNIQUE MECHANISM USING FX AND FXA/
    Blood
    
    P.W. Bergum et al., "THE ANTICOAGULANT STRATEGY OF THE HOOKWORM A-CANINUM - POTENT INHIBITION OF HUMAN-FACTORS XA (FXA) AND VIIA TF BY A UNIQUE MECHANISM USING FX AND FXA/", Blood, 86(10), 1995, pp. 3448-3448
30. MOYLE M; FOSTER DL; MCGRATH DE; BROWN SM; LAROCHE Y; DEMEUTTER J; STANSSENS P; BOGOWITZ CA; FRIED VA; ELY JA; SOULE HR; VLASUK GP
    A HOOKWORM GLYCOPROTEIN THAT INHIBITS NEUTROPHIL FUNCTION IS A LIGANDOF THE INTEGRIN CD11B CD18
    The Journal of biological chemistry
    
    M. Moyle et al., "A HOOKWORM GLYCOPROTEIN THAT INHIBITS NEUTROPHIL FUNCTION IS A LIGANDOF THE INTEGRIN CD11B CD18", The Journal of biological chemistry, 269(13), 1994, pp. 10008-10015
31. RICHARD BM; NOLAN TG; TRAN HS; MILLER MM; NUTT RF; VLASUK GP
    BIOAVAILABILITY OF A NOVEL DIRECT THROMBIN INHIBITOR IN NONHUMAN-PRIMATES FOLLOWING ORAL-ADMINISTRATION
    Circulation
    
    B.M. Richard et al., "BIOAVAILABILITY OF A NOVEL DIRECT THROMBIN INHIBITOR IN NONHUMAN-PRIMATES FOLLOWING ORAL-ADMINISTRATION", Circulation, 90(4), 1994, pp. 180-180
32. RICHARD BM; NOLAN TG; TRAN HS; MILLER MM; NUTT RF; VLASUK GP
    BIOAVAILABILITY OF A NOVEL DIRECT THROMBIN INHIBITOR IN NONHUMAN-PRIMATES FOLLOWING ORAL-ADMINISTRATION
    Circulation
    
    B.M. Richard et al., "BIOAVAILABILITY OF A NOVEL DIRECT THROMBIN INHIBITOR IN NONHUMAN-PRIMATES FOLLOWING ORAL-ADMINISTRATION", Circulation, 90(4), 1994, pp. 180-180
33. ROTE WE; DEMPSEY EM; OLDESCHULTE GL; ARDECKY RJ; TAMURA SY; NUTT RF; BERGUM PW; TRAN HS; ANDERSON SM; VLASUK GP
    EVALUATION OF A NOVEL ORALLY-ACTIVE DIRECT INHIBITOR OF THROMBIN IN ANIMAL-MODELS OF THROMBOSIS
    Circulation
    
    W.E. Rote et al., "EVALUATION OF A NOVEL ORALLY-ACTIVE DIRECT INHIBITOR OF THROMBIN IN ANIMAL-MODELS OF THROMBOSIS", Circulation, 90(4), 1994, pp. 344-344
34. ROTE WE; DEMPSEY EM; OLDESCHULTE GL; ARDECKY RJ; TAMURA SY; NUTT RF; BERGUM PW; TRAN HS; ANDERSON SM; VLASUK GP
    EVALUATION OF A NOVEL ORALLY-ACTIVE DIRECT INHIBITOR OF THROMBIN IN ANIMAL-MODELS OF THROMBOSIS
    Circulation
    
    W.E. Rote et al., "EVALUATION OF A NOVEL ORALLY-ACTIVE DIRECT INHIBITOR OF THROMBIN IN ANIMAL-MODELS OF THROMBOSIS", Circulation, 90(4), 1994, pp. 344-344
35. VLASUK GP; VALLAR PL; WEINHOUSE MI; BERGUM PW; TRAN HS; WEITZ JI; TULINSKY A; KRISHNAN R; ROFE WE; OLDESCHULTE GL; PEARSON DA
    A NOVEL INHIBITOR OF THROMBIN CONTAINING MULTIPLE RECOGNITION SEQUENCES LINKED BY A ALPHA-KETO AMIDE TRANSITION-STATE MIMETIC
    Circulation
    
    G.P. Vlasuk et al., "A NOVEL INHIBITOR OF THROMBIN CONTAINING MULTIPLE RECOGNITION SEQUENCES LINKED BY A ALPHA-KETO AMIDE TRANSITION-STATE MIMETIC", Circulation, 90(4), 1994, pp. 348-348
36. VLASUK GP; VALLAR PL; WEINHOUSE MI; BERGUM PW; TRAN HS; WEITZ JI; TULINSKY A; KRISHNAN R; ROFE WE; OLDESCHULTE GL; PEARSON DA
    A NOVEL INHIBITOR OF THROMBIN CONTAINING MULTIPLE RECOGNITION SEQUENCES LINKED BY A ALPHA-KETO AMIDE TRANSITION-STATE MIMETIC
    Circulation
    
    G.P. Vlasuk et al., "A NOVEL INHIBITOR OF THROMBIN CONTAINING MULTIPLE RECOGNITION SEQUENCES LINKED BY A ALPHA-KETO AMIDE TRANSITION-STATE MIMETIC", Circulation, 90(4), 1994, pp. 348-348
37. RAGOSTA M; GIMPLE LW; GERTZ SD; DUNWIDDIE CT; VLASUK GP; HABER HL; POWERS ER; ROBERTS WC; SAREMBOCK IJ
    SPECIFIC FACTOR XA INHIBITION REDUCES RESTENOSIS AFTER BALLOON ANGIOPLASTY OF ATHEROSCLEROTIC FEMORAL ARTERIES IN RABBITS
    Circulation
    
    M. Ragosta et al., "SPECIFIC FACTOR XA INHIBITION REDUCES RESTENOSIS AFTER BALLOON ANGIOPLASTY OF ATHEROSCLEROTIC FEMORAL ARTERIES IN RABBITS", Circulation, 89(3), 1994, pp. 1262-1271
38. LYNCH JJ; SITKO GR; MELLOTT MJ; NUTT EM; LEHMAN ED; FRIEDMAN PA; DUNWIDDIE CT; VLASUK GP
    MAINTENANCE OF CANINE CORONARY-ARTERY PATENCY FOLLOWING THROMBOLYSIS WITH FRONT LOADED PLUS LOW-DOSE MAINTENANCE CONJUNCTIVE THERAPY - A COMPARISON OF FACTOR XA VERSUS THROMBIN INHIBITION
    Cardiovascular Research
    
    J.J. Lynch et al., "MAINTENANCE OF CANINE CORONARY-ARTERY PATENCY FOLLOWING THROMBOLYSIS WITH FRONT LOADED PLUS LOW-DOSE MAINTENANCE CONJUNCTIVE THERAPY - A COMPARISON OF FACTOR XA VERSUS THROMBIN INHIBITION", Cardiovascular Research, 28(1), 1994, pp. 78-85
39. KRISHNASWAMY S; VLASUK GP; BERGUM PW
    ASSEMBLY OF THE PROTHROMBINASE COMPLEX ENHANCES THE INHIBITION OF BOVINE FACTOR XA BY TICK ANTICOAGULANT PEPTIDE
    Biochemistry
    
    S. Krishnaswamy et al., "ASSEMBLY OF THE PROTHROMBINASE COMPLEX ENHANCES THE INHIBITION OF BOVINE FACTOR XA BY TICK ANTICOAGULANT PEPTIDE", Biochemistry, 33(25), 1994, pp. 7897-7907
40. VLASUK GP
    STRUCTURAL AND FUNCTIONAL-CHARACTERIZATION OF TICK ANTICOAGULANT PEPTIDE (TAP) - A POTENT AND SELECTIVE INHIBITOR OF BLOOD-COAGULATION FACTOR XA
    Thrombosis and haemostasis
    
    G.P. Vlasuk, "STRUCTURAL AND FUNCTIONAL-CHARACTERIZATION OF TICK ANTICOAGULANT PEPTIDE (TAP) - A POTENT AND SELECTIVE INHIBITOR OF BLOOD-COAGULATION FACTOR XA", Thrombosis and haemostasis, 70(1), 1993, pp. 212-216
41. LAUWEREYS M; STANSSENS P; LAMBEIR AM; MESSENS J; DEMPSEY E; VLASUK GP
    ECOTIN AS A POTENT FACTOR-XA INHIBITOR
    Thrombosis and haemostasis
    
    M. Lauwereys et al., "ECOTIN AS A POTENT FACTOR-XA INHIBITOR", Thrombosis and haemostasis, 69(6), 1993, pp. 783-783
42. BERGUM PW; VLASUK GP; KRISHNASWAMY S
    FACTOR-VA(FVA) STABILIZES THE INHIBITORY COMPLEX BETWEEN TICK ANTICOAGULANT PROTEIN (TAP) AND FACTOR-XA (FXA)
    Thrombosis and haemostasis
    
    P.W. Bergum et al., "FACTOR-VA(FVA) STABILIZES THE INHIBITORY COMPLEX BETWEEN TICK ANTICOAGULANT PROTEIN (TAP) AND FACTOR-XA (FXA)", Thrombosis and haemostasis, 69(6), 1993, pp. 810-810
43. MELLOTT MJ; STRANIERI MT; SITKO GR; STABILITO II; LYNCH JJ; VLASUK GP
    ENHANCEMENT OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR-INDUCED REPERFUSION BY RECOMBINANT TICK ANTICOAGULANT PEPTIDE, A SELECTIVE FACTOR-XA INHIBITOR, IN A CANINE MODEL OF FEMORAL ARTERIAL THROMBOSIS
    Fibrinolysis
    
    M.J. Mellott et al., "ENHANCEMENT OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR-INDUCED REPERFUSION BY RECOMBINANT TICK ANTICOAGULANT PEPTIDE, A SELECTIVE FACTOR-XA INHIBITOR, IN A CANINE MODEL OF FEMORAL ARTERIAL THROMBOSIS", Fibrinolysis, 7(3), 1993, pp. 195-202
44. BERGUM PW; MAKI SL; HUANG S; VLASUK GP
    A MONOCLONAL-ANTIBODY (CVS-12D10) AGAINST HUMAN FACTOR-VII VIIA THAT INHIBITS THE ACTIVATION OF BOTH FACTOR-IX AND FACTOR-X/
    Blood
    
    P.W. Bergum et al., "A MONOCLONAL-ANTIBODY (CVS-12D10) AGAINST HUMAN FACTOR-VII VIIA THAT INHIBITS THE ACTIVATION OF BOTH FACTOR-IX AND FACTOR-X/", Blood, 82(10), 1993, pp. 10000064-10000064